Novavax Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights
Achieved revenues in fourth quarter 2022 of $357 million and full year 2022 of $2.0 billion Appointed John C. Jacobs as President and Chief Executive Officer...
Source: prnewswire.com